However, deregulated RhoH protein expression either through aSHM, lysosomal degradation, or transcriptional repression, has been associated with poor outcomes of B cell malignancies and immune-related diseases, such as immunodeficiency and autoimmune diseases. Here, RHOH is linked to immune system disorder.